Search

Displaying results 6651 - 6660 of 8517 in total
  1. Drug

    Uldazepam

    go.drugbank.com/drugs/DB21290
    Experimental

    Uldazepam has a monoisotopic molecular weight of 359.06 Da.

  2. Drug

    Fluradoline

    go.drugbank.com/drugs/DB21333
    Experimental

    Fluradoline has a monoisotopic molecular weight of 301.09 Da.

  3. Drug

    Pinoxepin

    go.drugbank.com/drugs/DB21397
    Experimental

    Pinoxepin has a monoisotopic molecular weight of 398.18 Da.

  4. Drug

    Ruzadolane

    go.drugbank.com/drugs/DB21444
    Experimental

    Ruzadolane has a monoisotopic molecular weight of 375.13 Da.

  5. Drug

    Tarlatamab

    go.drugbank.com/drugs/DB17256
    ApprovedInvestigational

    [L50743] Tarlatamab-dlle was approved by the FDA in May 2024 for use in patients who have failed previous round of platinum-based chemotherapy,[L50743,L50748] becoming the first DLL3-targeting bispecific

  6. Drug

    Orlistat

    go.drugbank.com/drugs/DB01083
    ApprovedInvestigational

    It was approved by the FDA for use in combination with a reduced-calorie diet in 1999.

  7. Drug

    Nitric Oxide

    go.drugbank.com/drugs/DB00435
    ApprovedInvestigational

    This gas is an important signaling molecule in the body of mammals including humans and is an extremely important intermediate in the chemical industry.

    Products: Neophyr 225 ppm mol/mol Gas zur medizinischen Anwendung, druckverdichtet, Neophyr 450 ppm mol/mol Gas zur medizinischen Anwendung, druckverdichtet
  8. Drug

    AV-412

    go.drugbank.com/drugs/DB06021
    Investigational

  9. Drug

    ASI402

    go.drugbank.com/drugs/DB06373
    Investigational

    ASI402 is a monoclonal antibody that targets an aberrantly glycosylated antigen Mucin 1. It is being investigated in cancers.

  10. Drug

    MDX-1379

    go.drugbank.com/drugs/DB05329
    Investigational

    MDX-1379 vaccine consists of two gp100 melanoma peptides. This drug is underinvestigation to treat malignant melanoma.